Pulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation
Recruiting
Observational Study
Infant, Preterm
Respiratory Distress Syndrome (Neonatal)
Chronic Lung Disease of Newborn
Respiratory Support
Synchronized Noninvasive Positive Pressure Ventilation (SNIPPV)
Lung Volume
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 4 Weeks
- Sex
- Any
- Study type
- Observational
- Participants needed
- 27 (estimated)
- Sponsor
- University of Zurich · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Current evidence suggests that noninvasive positive pressure ventilation (NIPPV) is more effective than continuous positive airway pressure (CPAP) in preventing respiratory failure in preterm infants with respiratory distress syndrome (RDS), both as initial and post-extubation support. NIPPV may be delivered in synchronized (sNIPPV) or non-synchronized (nsNIPPV) modes, with sNIPPV offering clear b…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Written informed consent by one or both parents or legal guardians
* Gestational age at birth \< 30 0/7 weeks
* Infants on sNIPPV respiratory support
* Below 4 weeks chronological age
Exclusion Criteria:
* Severe congenital malformation adversely affecting lung aeration or p…
Contacts